UBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalyst

NASDAQ:UBX   Unity Biotechnology, Inc.

and rises over 100 % in premarket, Has a new product
for macular degeneration, a widespread medical problem
affecting vision in the elderly which is increasing
in incidence. The earning beat was significant.

Chart demonstrates the uptrend and midrange
RSI but does not show today's premarket.

40 % rise in the week leading up to earnings and now parabolic.
doubling overnight.

* Get in the party now, don't be late. If you are
late stay home"

( not a recommendation to buy only education)

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.